ABIN953017

antibody from antibodies-online

Targeting: TRIM13 DLEU5, Leu5, RFP2, RNF77

Provider product page for ABIN953017

Western blot

Immunohistochemistry

Antibody data

Antibody Data
Antigen structure
References [5]
Comments [0]
Validations
Western blot [1]
Immunohistochemistry [1]

Submit

Product number: ABIN953017 - Provider product page
Provider: antibodies-online
Product name: anti-Potassium Channel Regulator (KCNRG) (AA 182-210), (C-Term) antibody
Antibody type: Polyclonal
Description: Protein A column, followed by peptide affinity purification
Reactivity: Human, Mouse
Host: Rabbit
Epitope: AA 182-210, C-Term
Vial size: 0.4 mL
Storage: Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Handling: Avoid repeated freezing and thawing.

TRIM13 protein structure - ABIN953017 shown in red.

Submitted references The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD.

Lerner M, Corcoran M, Cepeda D, Nielsen ML, Zubarev R, Pontén F, Uhlén M, Hober S, Grandér D, Sangfelt O
Molecular biology of the cell 2007 May;18(5):1670-82

Human RFP2 gene promoter: unique structure and unusual strength.

Skoblov M, Shakhbazov K, Oshchepkov D, Ivanov D, Guskova A, Ivanov D, Rubtsov P, Prasolov V, Yankovsky N, Baranova A
Biochemical and biophysical research communications 2006 Apr 14;342(3):859-66

DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse.

Corcoran MM, Hammarsund M, Zhu C, Lerner M, Kapanadze B, Wilson B, Larsson C, Forsberg L, Ibbotson RE, Einhorn S, Oscier DG, Grandér D, Sangfelt O
Genes, chromosomes & cancer 2004 Aug;40(4):285-97

The DNA sequence and analysis of human chromosome 13.

Dunham A, Matthews LH, Burton J, Ashurst JL, Howe KL, Ashcroft KJ, Beare DM, Burford DC, Hunt SE, Griffiths-Jones S, Jones MC, Keenan SJ, Oliver K, Scott CE, Ainscough R, Almeida JP, Ambrose KD, Andrews DT, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Bannerjee R, Barlow KF, Bates K, Beasley H, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burrill W, Carder C, Carter NP, Chapman JC, Clamp ME, Clark SY, Clarke G, Clee CM, Clegg SC, Cobley V, Collins JE, Corby N, Coville GJ, Deloukas P, Dhami P, Dunham I, Dunn M, Earthrowl ME, Ellington AG, Faulkner L, Frankish AG, Frankland J, French L, Garner P, Garnett J, Gilbert JG, Gilson CJ, Ghori J, Grafham DV, Gribble SM, Griffiths C, Hall RE, Hammond S, Harley JL, Hart EA, Heath PD, Howden PJ, Huckle EJ, Hunt PJ, Hunt AR, Johnson C, Johnson D, Kay M, Kimberley AM, King A, Laird GK, Langford CJ, Lawlor S, Leongamornlert DA, Lloyd DM, Lloyd C, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, McLaren SJ, McMurray A, Milne S, Moore MJ, Nickerson T, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter KM, Rice CM, Searle S, Sehra HK, Shownkeen R, Skuce CD, Smith M, Steward CA, Sycamore N, Tester J, Thomas DW, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, Whitehead SL, Willey DL, Wilming L, Wray PW, Wright MW, Young L, Coulson A, Durbin R, Hubbard T, Sulston JE, Beck S, Bentley DR, Rogers J, Ross MT
Nature 2004 Apr 1;428(6982):522-8

RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukemia.

van Everdink WJ, Baranova A, Lummen C, Tyazhelova T, Looman MW, Ivanov D, Verlind E, Pestova A, Faber H, van der Veen AY, Yankovsky N, Vellenga E, Buys CH
Cancer genetics and cytogenetics 2003 Oct 1;146(1):48-57